Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Ian Frazer Centre for Children’s Immunotherapy Research

Professor Di Yu is an immunologist, global highly cited researcher, and NHMRC Leadership Fellow. He is internationally recognised for the discovery of novel T lymphocyte subsets and their molecular regulators, relevant to health and disease. Bridging the gap between basic immunology and translation, Professor Yu actively collaborates with clinicians and has initiated clinical studies and trials for immune-related disease and immunisation. One such example is the investigator-driven trials of low-dose interleukin-2 therapy in lupus, which have altered clinical practice.

Professor Yu achievements in basic research and translation have been recognised by several awards, including the Academy’s Jian Zhou Medal.

Executive Dean, Faculty of Health
Queensland University of Technology

Distinguished Professor Patsy Yates is over 20 years post-PhD and is a leading authority in palliative care services research. She has significant original contributions that have had a positive impact on health and medical research, the health system, economy and/or the health of the population, particularly in cancer and palliative care services.

Distinguished Professor Yates has led major independent programs involving national and international collaborative networks and she has an extensive mentoring and leadership portfolio. She is currently Executive Dean (Faculty of Health) at Queensland University of Technology, Centre Director for the Centre for Healthcare Transformation, and Director of the Centre for Palliative Care Research and Education, Queensland Health.

Professorial Research Fellow
Menzies Institute for Medical Research

Professor Bruce Taylor is a clinician-scientist who leads a large and diverse research group, undertaking internationally significant research in the field of neuroscience. He is also a senior consultant neurologist with a special interest in multiple sclerosis (MS).

Professor Taylor’s research focuses on the personal, environmental and genetic factors associated with the onset and progression of MS. This work has resulted in significant breakthroughs in our understanding of the aetiology of MS and the factors associated with the highly variable progression of MS. Through his work, Professor Taylor has made significant contributions into the understanding of the role of the environment in MS onset and progression.

Professor of Urban Transport and Public Health
The University of Melbourne

Professor Mark Stevenson is an internationally renowned epidemiologist whose research and advocacy have led to transport and public health policies that have reduced the global burden of injury. His landmark research associated with mobile phone use and the risk of car crash led to legislative change across five countries. Additionally, his research on young driver crashes has influenced licensing policies in Australia and his research on toddler drownings has led to legislation requiring four-sided isolation pool fencing.

Professor Stevenson’s leadership and mentorship have been recognised, internationally, and his ability to deliver injury prevention interventions into mainstream systems, highlight the enormous utility of his work.

Consultant Medical Oncologist
Peter MacCallum Cancer Centre

Professor Ben Solomon is a clinician-scientist whose clinical and translational research has identified new treatments, changed standards of care and improved outcomes for patients with lung cancer, the leading cause of cancer-related death. His work has resulted in regulatory approvals for first, second and third generation ALK TKIs, defining new and transformative standards of care in this population.

Professor Solomon’s ongoing leadership role in global clinical trials and as scientific chair and founding board member of the Thoracic Oncology Group of Australasia will ensure conduct and implementation of research that improves outcomes for lung cancer patients in Australia and worldwide.

Professor, School of Pharmacy
The University of Queensland

Professor Jason Roberts has been instrumental in guiding evidence-based dosing of antimicrobials in critically ill patients with serious infections. This work has been recognised internationally for its global impact and he is the most published author in this field worldwide, as his findings form the basis of numerous therapeutic guidelines.

Professor Roberts has a substantial record in mentoring both pharmacists and physicians in research methods, with trainees coming to Australia from many parts of the world specifically to be guided by him.

Academic Head, School of Psychological Sciences; Deputy Director, Turner Institute for Brain and Mental Health
Monash University

Professor Shantha Rajaratnam’s research has taken circadian neuroscience into new clinical approaches: melatonin agonist (to FDA approval), light therapy and digital applications. He has published more than 165 peer-reviewed papers and two edited books, and he has led the peak body for sleep health and medicine (Australasian Sleep Association). He currently leads the Sleep Health Foundation.

Professor Rajaratnam was a Program Leader for the Alertness CRC (>$90 million), and a Chief Investigator on two NHMRC Centres for Research Excellence. At Monash, he established a multi-disciplinary sleep research program (now with nine labs), and a sleep research network across the university and six affiliated hospitals.

Pro Vice Chancellor (Health and Medical Research)
The University of Western Australia

Professor Anna Nowak is a medical oncologist, clinical triallist and tumour immunology researcher with a focus on the cancer mesothelioma. She developed the first measurement criteria specific to the unique growth pattern of mesothelioma, which are used in clinical trials worldwide. Professor Nowak was an early investigator of chemo-immunotherapy combinations in the laboratory, advancing our understanding of synergy between these treatments. She has subsequently progressed this work to a number of human clinical trials of chemo-immunotherapy, with a recent efficacious combination progressing through to an international randomised clinical trial.

Professor Nowak is currently Pro Vice Chancellor (Health and Medical Research) at UWA.

Head, School of Clinical Sciences
Monash University

Professor Eric Morand is an internationally renowned academic physician-scientist. His career has focused on integrating clinical and laboratory science to advance patient outcomes in lupus.

Professor Morand founded a multinational consortium to design and validate new clinical endpoints, solving a decade-long impasse responsible for multiple failed trials. He led the breakthrough Phase 3 trial of the novel medicine anifrolumab, resulting in approval of only the second new medicine for lupus in 60 years and formally validating a key aspect of SLE pathogenesis. Professor Morand’s work identifying molecular targets for an alternative to steroids won the highest award of the Lupus Research Alliance, US.

Professor and Laboratory Head
The Doherty Institute

Professor Laura Mackay is a Howard Hughes and Bill and Melinda Gates-funded International Scholar, Sylvia and Charles Viertel Senior Research Fellow, NHMRC Leadership Fellow and Dame Kate Campbell Fellow. She has is an internationally recognised expert in T cell immunity, contributing landmark papers that have defined how memory T cell responses are generated in body tissues (Science, Nature, Nature Immunol, Nature Medicine, Immunity).

Professor Mackay’s work has been recognized by prestigious fellowships, international grant funding, speaking invitations and Awards including The Gottschalk Medal (AAS) and Prime Minister’s Prize for Frank Fenner Life Scientist of the Year.

About Fellowship with AAHMS

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.